Mingzhe Ma
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Complement system in diseases
Papers in
-
- Cancer-related molecular mechanisms research 4
-
- Catalysts for Methane Reforming 3
- Co-authors
- Mingzhe Weng (4 shared papers)Yiren Hu (4 shared papers)Hui Yang (5 shared papers)Kun Lv (5 shared papers)Ye Hu (3 shared papers)Xiaocen Liu (3 shared papers)Denise A. Croix (1 shared paper)Ariella Mirowski Rosengard (1 shared paper)
- Journals
- World Journal of Gastroenterology (2 papers)Cell Death and Disease (2 papers)Free Radical Biology and Medicine (1 paper)Biochar (1 paper)Molecular Therapy (1 paper)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Mingzhe Ma
24 papers receiving 1.1k citations
Mingzhe Ma's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 345
- Immunology 222
- Molecular Biology 443
- Management, Monitoring, Policy and Law 78
- Pulmonary and Respiratory Medicine 181
Countries citing papers authored by Mingzhe Ma
This map shows the geographic impact of Mingzhe Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzhe Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzhe Ma more than expected).
Fields of papers citing papers by Mingzhe Ma
This network shows the impact of papers produced by Mingzhe Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzhe Ma. The network helps show where Mingzhe Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingzhe Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 212 | |
| 2 | 1996 | 199 | |
| 3 | 2018 | 115 | |
| 4 | 2016 | 85 | |
| 5 | 2013 | 81 | |
| 6 | Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer Hit paper breakdown → | 2024 | 71 |
| 7 | 2022 | 60 | |
| 8 | 2018 | 43 | |
| 9 | 2022 | 41 | |
| 10 | 2021 | 39 | |
| 11 | 2019 | 30 | |
| 12 | 2022 | 28 | |
| 13 | 2023 | 19 | |
| 14 | 2021 | 18 | |
| 15 | 2024 | 18 | |
| 16 | 2024 | 16 | |
| 17 | 2024 | 10 | |
| 18 | 2019 | 9 | |
| 19 | 2025 | 9 | |
| 20 | 2023 | 6 |
About Mingzhe Ma
Mingzhe Ma is a scholar working on Cancer Research, Catalysis, Process Chemistry and Technology, Molecular Biology and Safety, Risk, Reliability and Quality, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Catalytic Processes in Materials Science (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Ferroptosis and cancer prognosis (3 papers), Catalysts for Methane Reforming (3 papers), Glycosylation and Glycoproteins Research (2 papers), Geotechnical Engineering and Analysis (2 papers) and Catalysis and Hydrodesulfurization Studies (2 papers). The work is most often cited by research in Cancer Research (345 citations), Immunology (222 citations), Molecular Biology (443 citations), Management, Monitoring, Policy and Law (78 citations) and Pulmonary and Respiratory Medicine (181 citations). Mingzhe Ma has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Mingzhe Weng, Yiren Hu, Hui Yang, Kun Lv, Ye Hu, Xiaocen Liu, Denise A. Croix, Ariella Mirowski Rosengard, J M Ahearn and Garnett H. Kelsoe. Their work appears in journals such as World Journal of Gastroenterology, Cell Death and Disease, Free Radical Biology and Medicine, Biochar and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.